Cryofocus Medtech (Shanghai)'s (HKG:6922) attributable loss narrowed to 23.8 million yuan in the first half from 52.2 million yuan in the year-ago period, according to a Friday filing with the Hong Kong bourse.
Shares fell 5% during the close of trading on Monday.
Loss per share at the medical device company narrowed to 0.10 yuan from 0.22 yuan in the prior-year period.
Operating income increased to 51.1 million yuan from 19.5 million yuan in the year-ago period.